QB3

QB3
California Institute for Quantitative Biosciences · Public domain · source
Name	QB3
Type	Research institute
Founded	2000
Founders	Roger Kornberg, Irwin M. Jacobs
Headquarters	San Francisco, California
Location	University of California campuses: University of California, San Francisco, University of California, Berkeley, University of California, Santa Cruz
Focus	Biotechnology, life sciences, entrepreneurship

QB3 QB3 is a University of California life sciences research institute and innovation hub that connects faculty, students, entrepreneurs, and industry across multiple campuses. It supports translational research, startup formation, and interdisciplinary collaboration among scientists from diverse backgrounds at University of California, Berkeley, University of California, San Francisco, and University of California, Santa Cruz. The institute emphasizes partnerships with private firms, venture investors, and federal agencies to accelerate commercialization of research stemming from campus laboratories.

Overview

QB3 serves as a bridge among academic laboratories, biotechnology startups, and established companies in the San Francisco Bay Area and beyond. It fosters translational projects spanning molecular biology, chemical biology, synthetic biology, and biomedical engineering, linking investigators at Stanford University, Lawrence Berkeley National Laboratory, California Institute for Quantitative Biosciences-affiliated campuses, and regional incubators. Programs often intersect with initiatives sponsored by the National Institutes of Health, National Science Foundation, and state economic development offices. Facilities and services include wet-lab coworking spaces, business incubators, high-throughput screening cores, and industry liaison offices.

History

QB3 was established at the turn of the 21st century to capitalize on the research strengths of multiple University of California campuses and the entrepreneurial ecosystem of the Bay Area. Early leadership included faculty who had received honors such as the Nobel Prize in Chemistry and collaborators from major biotech firms like Genentech and Amgen. Through the 2000s and 2010s, QB3 expanded its footprint with incubator sites in San Francisco and South San Francisco, aligning with regional trends such as the growth of Mission Bay biotech developments and the rise of venture funds like Benchmark (venture capital firm) and Sequoia Capital. The institute responded to national calls for translational research exemplified by programs like the Small Business Innovation Research and Small Business Technology Transfer grants.

Organization and Governance

QB3 operates as a University of California entity with governance ties to campus administrations at UCSF, UC Berkeley, and UC Santa Cruz. Its advisory structures have included industry executives from firms such as Genentech, Gilead Sciences, and Johnson & Johnson alongside academic leaders from departments including Biochemistry and Biophysics, Chemical and Biomolecular Engineering, and Molecular, Cell and Developmental Biology. Oversight and strategic guidance have involved boards that interact with technology transfer offices like those at Berkeley Technology Licensing and UCSF Office of Innovation, Technology and Alliances.

Research Centers and Initiatives

QB3 sponsors and hosts thematic research centers that emphasize interdisciplinary approaches. Initiatives have included high-throughput screening cores comparable to facilities at Broad Institute, structural biology collaborations linked to groups at Lawrence Livermore National Laboratory, and computational biology efforts that dovetail with researchers at University of California, San Diego and Stanford School of Medicine. The institute has supported programs in synthetic biology and genome engineering that intersect with initiatives led by figures associated with CRISPR research and biotechnology consortia. Collaborative projects often partner with regional centers such as the BayBio network and national consortia funded by agencies like DARPA.

Education and Training Programs

QB3 runs training programs for graduate students, postdoctoral scholars, and entrepreneurs offering coursework and experiential learning in commercialization, regulatory affairs, and science policy. Participants engage with curricula that reference precedents from programs at Harvard University, MIT, and executive education models from Stanford Graduate School of Business. Internships and fellowships link trainees to biotech startups, venture capital firms including Khosla Ventures, and translational programs affiliated with California Institute for Regenerative Medicine. Workshops cover topics from intellectual property strategies used at USPTO-influenced filings to clinical development pathways resembling those navigated by companies collaborating with the Food and Drug Administration.

Industry Partnerships and Technology Transfer

QB3 maintains active partnerships with pharmaceutical and biotech companies as well as investor networks to facilitate licensing, sponsored research, and startup formation. It coordinates with technology transfer offices to shepherd inventions toward commercialization and has helped spin out companies that secured seed funding from firms like Third Rock Ventures and Flagship Pioneering. The institute’s incubators and lab-share programs provide onsite business development support similar to models used by accelerators such as Y Combinator and IndieBio.

Notable Research and Achievements

Work associated with QB3-affiliated faculty has contributed to advances in molecular structure determination, single-molecule biophysics, chemical probes for biological pathways, and methods in synthetic biology. Achievements include collaborations that informed drug discovery projects with partners like Genentech and platform technologies that attracted interest from biotechnology firms and federal grant programs. Faculty and alumni have been recognized with awards including the Lasker Award and nominations for the Nobel Prize in Chemistry; spinouts have advanced candidates into preclinical and clinical development with partnerships involving contract research organizations and pharmaceutical companies.

Funding and Facilities

Funding for QB3 activities combines state allocations, federal grants from agencies such as the National Institutes of Health and National Science Foundation, philanthropic donations from foundations and individuals, and revenue from industry-sponsored projects and incubator leases. Facilities under QB3’s umbrella include laboratory suites located near Mission Bay, shared instrumentation cores comparable to university core facilities, and collaborative office spaces that support interactions with venture capital firms and corporate partners headquartered in the San Francisco Bay Area.

Category:University of California Category:Biotechnology organizations in the United States